Global Antiemetic Drug Market 2017-2021
- SKU ID : TNV-IRTNTR13557 10711437
- |
- Publishing Date: 14-Jun-2017
- |
- Region: Global
- |
- No. of pages: 70
About Antiemetic Drug
Emesis is defined as forceful expulsion of stomach content either due to humoral stimulation due to chemoreceptor trigger zone (CRTZ) or neural stimulation of emetic centers. The various drugs that are used to treat this condition of emesis are known as antiemetics. The various classes of drug available for management of emesis are serotonin antagonist, dopamine antagonist, NK1 receptor antagonist, antihistaminic, steroids, and anticholinergic. The various applications of antiemetic drugs include chemotherapy, surgery, gastroenteritis, morning sickness, motion sickness, stress-induced emesis, and drugs-induced emesis. This market is primarily volume driven as majority of drugs are available in generic form.
Technavio’s analysts forecast the global antiemetic drug market to grow at a CAGR of 6.13% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global antiemetic drug market for 2017-2021. To calculate the market size, the report considers the sales from branded, generic, and off-label drugs.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Antiemetic Drug Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• GlaxoSmithKline
• Johnson & Johnson
• Pfizer
• Sanofi
Other prominent vendors
• Abbott
• Bristol-Myers Squibb
• Cipla
• Eisai
• Eli Lilly
• Glenmark
• Helsinn Healthcare
• Heron Therapeutics
• IPCA Laboratories
• Lupin
• Merck
• Novartis
• RedHill
• Sun Pharmaceutical Industries
• Takeda Pharmaceutical
Market driver
• Increased prevalence of cancer
• For a full, detailed list, view our report
Market challenge
• Lack of animal models
• For a full, detailed list, view our report
Market trend
• Inorganic growth strategies
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Emesis is defined as forceful expulsion of stomach content either due to humoral stimulation due to chemoreceptor trigger zone (CRTZ) or neural stimulation of emetic centers. The various drugs that are used to treat this condition of emesis are known as antiemetics. The various classes of drug available for management of emesis are serotonin antagonist, dopamine antagonist, NK1 receptor antagonist, antihistaminic, steroids, and anticholinergic. The various applications of antiemetic drugs include chemotherapy, surgery, gastroenteritis, morning sickness, motion sickness, stress-induced emesis, and drugs-induced emesis. This market is primarily volume driven as majority of drugs are available in generic form.
Technavio’s analysts forecast the global antiemetic drug market to grow at a CAGR of 6.13% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global antiemetic drug market for 2017-2021. To calculate the market size, the report considers the sales from branded, generic, and off-label drugs.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Antiemetic Drug Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• GlaxoSmithKline
• Johnson & Johnson
• Pfizer
• Sanofi
Other prominent vendors
• Abbott
• Bristol-Myers Squibb
• Cipla
• Eisai
• Eli Lilly
• Glenmark
• Helsinn Healthcare
• Heron Therapeutics
• IPCA Laboratories
• Lupin
• Merck
• Novartis
• RedHill
• Sun Pharmaceutical Industries
• Takeda Pharmaceutical
Market driver
• Increased prevalence of cancer
• For a full, detailed list, view our report
Market challenge
• Lack of animal models
• For a full, detailed list, view our report
Market trend
• Inorganic growth strategies
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
